News Levitee Labs Inc.

Equities

LVT

CA5274241051

Market Closed - Canadian Securities Exchange Other stock markets 11:03:02 2023-02-01 am EST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2022	Levitee Labs Inc. Announces Executive Changes	CI
2022	Levitee Labs Inc. Announces CEO Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IIROC Trading Halt - LVT	23-02-06	AQ
Levitee Labs Inc. Announces Executive Changes	22-06-20	CI
Levitee Labs Inc. Announces CEO Changes	22-06-20	CI
Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million	22-02-01	AQ
Levitee Labs Inc. Announces Philip Van Den Berg to Join as Interim CEO	22-02-01	CI
Levitee Labs Inc. Announces Philip Van Den Berg to Join the Board of Directors	22-02-01	CI
Levitee Labs Announces Non-Brokered Private Placement of up to $3,000,000	22-01-18	AQ
Levitee Labs Inc. announced that it expects to receive CAD 3 million in funding	22-01-17	CI
Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals	22-01-12	AQ
Levitee Labs Inc Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals	22-01-12	CI
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids	22-01-10	AQ
Levitee Labs Inc. Enters into A Strategic Partnership Via A Services Agreement with Canntab Therapeutics Limited	22-01-10	CI
CORRECTION - Levitee Labs Announces Medical Advisory Board	22-01-06	GL
Levitee Labs Inc. Appoints Maigul Wickham as its Chief Financial Officer Replacing Mason Darabi	22-01-06	CI
Levitee Labs Announces Medical Advisory Board	22-01-06	AQ
Levitee Labs Announces Medical Advisory Board	22-01-06	CI
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada	21-12-20	AQ
Levitee Labs Inc. Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care Throughout Alberta, Canada	21-12-20	CI
Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region	21-11-15	AQ
Levitee Labs Inc. Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region	21-11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Levitee Labs Inc.

Equities

LVT

CA5274241051

Summary

Filters